President Trump’s proposed tariffs on Denmark could have costly consequences for Americans relying on GLP-1 medications like ...

"They’re priced for profits, not patients.” That’s the critique from Hims & Hers Health’s buzzy — and controversial — Super ...

Alexandra Sowa's new book The Ozempic Revolution is intended to be the "first comprehensive user guide" to GLP-1 drugs like ...

Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...

The study may suggest that other researchers should be less optimistic about the prospects for treating a range of other ...

Novo Nordisk sells the drug semaglutide under the brands Ozempic for diabetes and Wegovy for weight loss. The company's older weight loss drug, liraglutide, is marketed as Victoza for diabetes and ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications ... The guide linked here is the AstraZeneca brand of Byetta.

Experts are calling on the government to implement strategies that will better predict future Ozempic shortages.

Spencer Durham can be reached at 765-454-8598, by email at [email protected] or on Twitter at @Durham_KT.

Patients testing a new weight-loss drug developed by the creators of Ozempic have revealed the extreme effects it had on their bodies. Danish pharma giant Novo Nordisk has been tight-lipped ...

Ozempic-Type Drug Fails To Slow Parkinson’s, Study Finds By India Edwards HealthDay Reporter WEDNESDAY, Feb. 5, 2025 (HealthDay News) -- Hopes that GLP-1 drugs such as Ozempic and Wegovy could ...